The push to bring insulin prices down in America

But not all patients are able to use the available schemes

Insulin and other diabetes medications are among the most-needed by the pharmacyâs clients, most of whom live well below federal poverty levels. Because of high drug prices, plus steep out-of-pocket expenses, many people, especially those with chronic illnesses, skimp on doses to make them last longer or donât take them because they canât afford them. (Emily Curiel/Kansas City Star/Tribune News Service via Getty Images) — Image: Getty Images

May 25th 2023|WASHINGTON, DC

“Move to the back if you’ve lost your life savings to the drug companies,” shouts a woman walking by your correspondent. A spirited group follows her to the end of a long queue for a Senate hearing on insulin prices on May 10th. In the room David Ricks of Eli Lilly, a large American drug firm, testifies that insulin, used to regulate blood-sugar levels for diabetics, is cheap and even free in some instances. “If you contact Lilly today, we will ship you a month’s supply at no cost with one question: ‘What’s your address?’” he says. Those dressed in gear with slogans like “Insulin for All” shake their heads in disbelief. Drug companies may be offering cheap insulin, but it is not reaching all patients.

This article appeared in the United States section of the print edition under the headline “Problem solved?”